|Bid||105.18 x 900|
|Ask||105.41 x 1200|
|Day's Range||104.24 - 105.55|
|52 Week Range||73.42 - 116.81|
|Beta (5Y Monthly)||0.53|
|PE Ratio (TTM)||108.68|
|Earnings Date||Apr 21, 2020 - Apr 26, 2020|
|Forward Dividend & Yield||0.80 (0.76%)|
|Ex-Dividend Date||Dec 11, 2019|
|1y Target Est||124.00|
CONMED Corporation (NYSE: CNMD) today announced that Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the 9th Annual SVB Leerink Global Healthcare Conference at 10:30 a.m. ET on Wednesday, February 26, 2020 in New York, NY.
CONMED's (CNMD) fourth-quarter earnings gain from higher revenues and strong performance in General Surgery segment. However, high long-term debt remains a concern.
Today we'll evaluate CONMED Corporation (NASDAQ:CNMD) to determine whether it could have potential as an investment...
Conmed (CNMD) delivered earnings and revenue surprises of 1.12% and 0.01%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
CONMED Corporation (NASDAQ: CNMD) today announced that it is transferring the listing of its common stock to the New York Stock Exchange (NYSE) from the NASDAQ Global Market.
CONMED Corporation (Nasdaq: CNMD) today announced financial results for the fourth quarter and full year ended December 31, 2019.
A series of product launches despite the ongoing regulatory hurdles is likely to favor revenues in the medical products space this earnings season.
Conmed (CNMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CONMED Corporation (NASDAQ: CNMD) today announced that it will report financial results for the fourth quarter and full year 2019 after the market close on Wednesday, January 29, 2020. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
With earnings on tap for Jan. 20, ConMed is currently approximately 4% below a 116.91 buy point. The pattern is a second-stage flat base. Keep in mind that jumping into a stock right as it gets ready to report means you likely won't have enough time to build a profit cushion before the release.
CONMED Corporation (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the 38th Annual J.P. Morgan Healthcare Conference at 4:30 p.m. PT on Monday, January 13, 2020 in San Francisco, CA.
Patterson Companies (PDCO) continues to benefit from robust product portfolio, strong prospects in Animal Health unit and strategic buyouts.
Pacific Biosciences (PACB) continues to gain from innovative product portfolio and Sequel system. However, stiff competition remains a woe.
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...